Randomised phase II window study of short term preoperative treatment with the PI3K inhibitor GDC0941 plus Anastrozole versus Anastrozole alone in patients with ERpositive primary breast cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Pictrelisib (Primary) ; Anastrozole
- Indications Breast cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Acronyms OPPORTUNE
- 14 Mar 2016 Results (n = 75) published in the Journal of Clinical Oncology.
- 28 Jan 2016 Status changed from recruiting to completed according to United Kingdom Clinical Research Network.
- 12 Dec 2015 Interim results (n=70) presented at the 38th Annual San Antonio Breast Cancer Symposium.